Moreover, WHO grade, IDH status, 1p/19q codeletion, primary therapy outcome, age, and MK3 expression were all significantly correlated with poor OS (Table 3), which indicated their association with the OS in glioma. The gene discussed is MAPKAPK3; the disease is central nervous system cancer.